ANXA1 and intracranial thrombosis: Furthermore, targeting SCD neutrophils with a pro-resolution molecule Annexin A1(AnxA1)Ac2-26 resulted in decreased H3Cit+ NETs from SCD neutrophils and reduced cerebral thrombosis in sickle transgenic mice [4].